Treatment of Open-Angle Glaucoma and Ocular Hypertension with Preservative-Free Tafluprost/Timolol Fixed-Dose Combination Therapy: UK and Ireland Results from the VISIONARY Study

Ansari E., Pavicic-Astalos J., Ayan F., King A.J., Kinsella M., Ng E., Nita A., The VISIONARY Group

2021
Advances in Therapy

Therapeutic Area

Glaucoma
Categories

Clinical development

Affiliations

Ansari, E., Maidstone and Tunbridge Wells NHS Trust, University of Kent at Canterbury, Kent, United Kingdom; Pavicic-Astalos, J., Institute of Eye Surgery, UPMC Whitfield, Waterford, Ireland; Ayan, F., Santen UK Ltd, St Albans, United Kingdom; King, A.J., Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom; Kinsella, M., Buckinghamshire Healthcare NHS Trust, Stoke Mandeville Hospital, Aylesbury, Buckinghamshire, United Kingdom; Ng, E., Institute of Eye Surgery, UPMC Whitfield, Waterford, Ireland; Nita, A., Royal Victoria Infirmary, The Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom; The VISIONARY Group

Related Publications

Associations between Clustered Visual Field Progression and Locations of Disc Hemorrhages in Glaucoma: A Three-year Prospective Study

Akagi T.; Fukuchi T.; Higashide T.; Udagawa S.; Ohkubo S.; Sugiyama K.; Tanihara H.; Araie M.; Tomita G.; Matsumoto C.; Tomidokoro A.; Hangai M.; Kawata H.; Inai M.; Tanaka Y.; SVF Prospector Study Group

Proteome-Wide Analysis of Autoantibodies in Open-Angle Glaucoma in Japanese Population: A Pilot Study

Takada N.; Ishikawa M.; Sato K.; Kunikata H.; Ninomiya T.; Hanyuda A.; Fukuda E.; Yamaguchi K.; Ono C.; Kirihara T.; Shintani C.; Tsusu C.; Osanai A.; Goshima N.; Izumi Y.; Zorumski C.F.; Nakazawa T.

Bioequivalence of Preservative-free and Preserved Omidenepag Isopropyl (OMDI) 0.002% Ophthalmic Solutions in Patients with Primary Open-Angle Glaucoma or Ocular Hypertension: Results from the Phase 3 DAISY Study

Aihara M.; Lu F.; Ikeda T.; Odani-Kawabata N.

View all Glaucoma publications